{"groups":[{"description":"Ibrutinib 560 mg on Days 1-28,\\> Lenalidomide 15 mg on Days 1-21 Dexamethasone 40 mg on Days 1,8,15, 22\\>\n\n\\> Every 28 days","id":"FG000","title":"Dose Level 1 (Starting DL)"},{"description":"Ibrutinib 560 mg on Days 1-28,\\> Lenalidomide 25 mg on Days 1-21 Dexamethasone 40 mg on Days 1,8,15, 22\\>\n\n\\> Every 28 days","id":"FG001","title":"Dose Level 2"},{"description":"Ibrutinib 840 mg on Days 1-28,\\> Lenalidomide 25 mg on Days 1-21 Dexamethasone 40 mg on Days 1,8,15, 22\\>\n\n\\> Every 28 days","id":"FG002","title":"Dose Level 3"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"4"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"4"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}